[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369960-105":59,"doc-detail-369960-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","smug1-promoted-the-progression-of-pancreatic-cancer-via-akt-signaling-pathway-through-binding-with-foxq1","SMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1","","Pancreatic cancer is a lethal malignancy often resistant to gemcitabine, and the base excision repair initiator SMUG1 has been linked to outcomes in multiple cancers, while its role in pancreatic cancer remained unclear. This study evaluated SMUG1 gene and protein expression and survival associations using bioinformatics and a Fudan University cohort, then tested cell proliferation, cell cycle, migration, DNA repair, apoptosis, and gemcitabine resistance in vitro. RNA sequencing and verification by qRT-PCR and Western blotting identified FOXQ1-mediated AKT/p21-p27 signaling and c-Myc stabilization; xenograft models confirmed the findings.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/smug1-promoted-the-progression-of-pancreatic-cancer-via-akt-signaling-pathway-through-binding-with-foxq1/369960/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/smug1-promoted-the-progression-of-pancreatic-cancer-via-akt-signaling-pathway-through-binding-with-foxq1/369960.png","ImageObject",300,407,{"name":92,"@type":93},"Guten tag","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main purpose regarding SMUG1 in pancreatic cancer?","Question",{"text":112,"@type":113},"To clarify how SMUG1 functions in pancreatic cancer, particularly whether it influences progression and gemcitabine resistance through defined signaling mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were SMUG1-related effects on pancreatic cancer cells tested?",{"text":117,"@type":113},"SMUG1 gene/protein expression and survival outcomes were assessed using bioinformatic analysis and a Fudan University cohort, then functional assays evaluated proliferation, G1-to-S transition, migration, DNA damage repair, apoptosis, and gemcitabine resistance in vitro.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular pathway connects SMUG1, FOXQ1, AKT signaling, and c-Myc?",{"text":121,"@type":113},"SMUG1 binds with FOXQ1 to activate the AKT/p21 and p27 pathway and stabilizes c-Myc protein via AKT signaling in pancreatic cancer cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369960,1790440746,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Original Article  \nSMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1  \nZijian Wu1,2,3,4,5, Wei Wang1,2,3,4, Jie Hua1,2,3,4, Jingyao Zhang6, Jiang Liu1,2,3,4, Si Shi1,2,3,4, Bo Zhang1,2,3,4, Xiaohui Wang5, Xianjun Yu1,2,3,4, Jin Xu1,2,3,4  \n1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China;  \n2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China;  \n3Shanghai Pancreatic Cancer Institute, Shanghai 200032, China;  \n4Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China;  \n5Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing 100053, China;  \n6Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.  \nAbstract  \nBackground: Pancreatic cancer is a lethal malignancy prone to gemcitabine resistance. The single-strand selective monofunctional uracil DNA glycosylase (SMUG1), which is responsible for initiating base excision repair, has been reported to predict the outcomes of different cancer types. However, the function of SMUG1 in pancreatic cancer is still unclear.  \nMethods: Gene and protein expression of SMUG1 as well as survival outcomes were assessed by bioinformatic analysis and verified in a cohort from Fudan University Shanghai Cancer Center. Subsequently, the effect of SMUG1 on proliferation, cell cycle, and migration abilities of SMUG1 cells were detected in vitro. DNA damage repair, apoptosis, and gemcitabine resistance were also tested. RNA sequencing was performed to determine the differentially expressed genes and signaling pathways, followed by quantitative real-time polymerase chain reaction and Western blotting verification. The cancer-promoting effect of forkhead box Q1 (FOXQ1) and SMUG1 on the ubiquitylation of myelocytomatosis oncogene (c-Myc) was also evaluated. Finally, a xenograft model was established to verify the results.  \nResults: SMUG1 was highly expressed in pancreatic tumor tissues and cells, which also predicted a poor prognosis. Downregulation of SMUG1 inhibited the proliferation, G1 to S transition, migration, and DNA damage repair ability against gemcitabine in pancreatic cancer cells. SMUG1 exerted its function by binding with FOXQ1 to activate the Protein Kinase B (AKT)/p21 and p27 pathway. Moreover, SMUG1 also stabilized the c-Myc protein via AKT signaling in pancreatic cancer cells.  \nConclusions: SMUG1 promotes proliferation, migration, gemcitabine resistance, and c-Myc protein stability in pancreatic cancer via protein kinase B signaling through binding with FOXQ1 . Furthermore, SMUG1 may be a new potential prognostic and gemcitabine resistance predictor in pancreatic ductal adenocarcinoma.  \nKeywords: Single-strand selective monofunctional uracil DNA glycosylase; Forkhead box Q1; Protein kinase B; Myelocytomatosis viral oncogene homolog; DNA damage; Gemcitabine; Pancreatic cancer  \nIntroduction  \nDue to its non-specific clinical symptoms and aggressive biological behavior, pancreatic cancer ranks 8th in mortality rate (4.7%) among all cancer types, with an extremely low five-year overall survival rate of approximately 11% . [1,2] In China, the incidences of pancreatic cancer have been on an annual upward trend for the past two decades, and were projected to hit alarming levels by 2022.[3] The lack of effective early screening for  \n\n| Access this article online |  |\n| --- | --- |\n| Quick Response Code: | Website:\u003Cbr>[www.cmj.org](www.cmj.org) |\n|  | DOI:\u003Cbr>10.1097/CM9.0000000000003640 |\n\nasymptomatic patients leads to micro-metastases with a limited resection rate (\u003C20%), and the treatments for pancreatic cancer are often palliative. [4,5]  \nCells of our body are always exposed to both internal ","cbCaivXfMaCqkrnr","https://ap.wps.com/l/cbCaivXfMaCqkrnr","pdf",35700520,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the study’s main purpose regarding SMUG1 in pancreatic cancer?\",\"answer\":\"To clarify how SMUG1 functions in pancreatic cancer, particularly whether it influences progression and gemcitabine resistance through defined signaling mechanisms.\"},{\"question\":\"How were SMUG1-related effects on pancreatic cancer cells tested?\",\"answer\":\"SMUG1 gene/protein expression and survival outcomes were assessed using bioinformatic analysis and a Fudan University cohort, then functional assays evaluated proliferation, G1-to-S transition, migration, DNA damage repair, apoptosis, and gemcitabine resistance in vitro.\"},{\"question\":\"What molecular pathway connects SMUG1, FOXQ1, AKT signaling, and c-Myc?\",\"answer\":\"SMUG1 binds with FOXQ1 to activate the AKT/p21 and p27 pathway and stabilizes c-Myc protein via AKT signaling in pancreatic cancer cells.\"}]","SMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1 | PDF",1790185630,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f773107be5651e590d1c76b22bce5841.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/088d31d6312f7d97a1700c6aaca4c5fd.webp",982,1323,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d48b9f483d74787a34ff84cd52f12b65.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcc45b5da5c767154bf0fea65b9a97fe.webp",980,1320]